News Focus
News Focus
icon url

Joeyohso

04/10/24 8:03 PM

#3308 RE: ShadowDiviner72 #3307

Also no debt and 90m+ in cash. That is unheard of for a research pharma company. They also are extending the employee stock purchase program for all of 2024. This stock is a gem